Overview

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

This study is designed to investigate the comparison between alpha blocker monotherapy and 5-alpha-reductase inhibitor monotherapy following combination therapy in benign prostatic hyperplasia.

Phase:

Phase 4

Details

Lead Sponsor:

Samsung Medical Center

Treatments:

5-alpha Reductase Inhibitors
Adrenergic alpha-Antagonists